The basal respiration offers insights into the basal status of oxidative phosphorylation (OXPHOS) in PBMC and comprises two components: mitochondrial ATP production and proton leak
PradalierABakouchePBaudessonGDelageACornaille-LafageGLaunayJMet al
5 In addition to approved indications, GLP-1 agonists may have a role in the management of cutaneous disease, as demonstrated through off-label treatment in the literature (Table 1)
Oral GLP-1 medicines are available for weight management, including orforglipron (Foundayo), approved by the FDA in April 2026, and an oral form of semaglutide
Vogel JH, Bolling SF, Costello RB, et al
Scientific Background Growth hormone release is regulated through complex endocrine signaling networks involving hypothalamic peptides and pituitary receptors